Francesco De Francesco | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Dr. Francesco De Francesco | Medicine and Dentistry | Best Researcher Award

Medical Surgeon | Azienda Ospedaliera Universitaria delle Marche | Italy

Dr. Francesco De Francesco is an accomplished clinician-scientist specializing in plastic, reconstructive, and regenerative surgery, with a strong academic background in stem cell biology and tissue engineering. His career reflects a balance of clinical expertise, laboratory research, and teaching, enabling him to translate scientific discoveries into therapeutic innovations. His work has focused extensively on adipose-derived stem cells, extracellular vesicles, and their applications in regenerative medicine, particularly in joint and soft tissue repair. Alongside his research, he has played an important role as a medical executive, advancing clinical practices in reconstructive and hand surgery. He has also contributed to academic training, fostering knowledge transfer and supporting the next generation of medical professionals. Recognized with national scientific qualifications and specialization, his profile reflects leadership, dedication, and significant impact in his field. His measurable research influence is demonstrated through Scopus with 3,218 citations, 122 documents, and an h-index of 30.

Profiles: Scopus | Google Scholar | ORCID

Featured Publications

1.  V. Tirino, V. Desiderio, F. Paino, A. De Rosa, F. Papaccio, M. La Noce, and F. De Francesco, “Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization,” The FASEB Journal, vol. 27, no. 1, pp. 13–24, 2013.

2. V. Tirino, V. Desiderio, R. d’Aquino, F. De Francesco, G. Pirozzi, U. Galderisi, and F. Papaccio, “Detection and characterization of CD133+ cancer stem cells in human solid tumours,” PLoS One, vol. 3, no. 10, p. e3469, 2008.

3. A. Graziano, R. d’Aquino, M. G. C. D. Angelis, F. De Francesco, A. Giordano, and G. Papaccio, “Scaffold’s surface geometry significantly affects human stem cell bone tissue engineering,” Journal of Cellular Physiology, vol. 214, no. 1, pp. 166–172, 2008.

4. F. De Francesco, G. Ricci, F. D’Andrea, G. F. Nicoletti, and G. A. Ferraro, “Human adipose stem cells: from bench to bedside,” Tissue Engineering Part B: Reviews, vol. 21, no. 6, pp. 572–584, 2015.

5. F. De Francesco, V. Tirino, V. Desiderio, G. Ferraro, F. D’Andrea, M. Giuliano, and F. Papaccio, “Human CD34+/CD90+ ASCs are capable of growing as sphere clusters, producing high levels of VEGF and forming capillaries,” PLoS One, vol. 4, no. 8, p. e6537, 2009.

Geng-Long Hsu | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Prof. Dr. Geng-Long Hsu | Medicine and Dentistry | Best Researcher Award

Director | Hsu’s Andrology | Taiwan

Prof. Dr. Geng-Long Hsu is a distinguished urologist and microsurgical potency reconstruction specialist with decades of experience in clinical practice, research, and education. He has pioneered innovative surgical techniques and contributed significant anatomical and physiological insights in male reproductive medicine. His leadership in multiple research centers and academic institutions has fostered a strong culture of mentorship and collaboration. Dr. Hsu is recognized internationally through memberships in professional societies and numerous awards for both basic and clinical research, highlighting the global impact of his work. His research demonstrates a consistent focus on advancing urological science, integrating clinical expertise with experimental innovation. Through his contributions, he has influenced treatment protocols and surgical outcomes in male reproductive health. His measurable research impact is reflected in Scopus, with 1,521 citations across 68 documents and an h-index of 22, underscoring the significance and reach of his scholarly work.

Profiles: Scopus | ORCID

Featured Publications

1. G.-L. Hsu, “Combining erection restoration and factual penile enhancement based on revolutionary penile fibro-vascular assembly,” Archivos Espanoles De Urologia, 2025.

2. G.-L. Hsu, “A detailed analysis of the penile fibro-vascular assembly,” Journal of Sexual Medicine, 2025.

3. G.-L. Hsu, “Coil embolization is not justified for treating patients with veno-occlusive dysfunction: Case series and narrative literature review,” Life, 2024.

4. G.-L. Hsu, “Emergent penile venous stripping for treating adolescent impotence,” Life, 2024.

5. G.-L. Hsu, “A case report of right cardiac ventricle perforation by uncontrolled embolization coil inserted for treating penile veno-occlusive dysfunction,” Urology Case Reports, 2022.

Dr. Javier Crespo | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Dr. Javier Crespo | Medicine and Dentistry | Best Researcher Award

Professor at IDIVAL, Spain

Professor Javier Crespo is a distinguished physician-scientist and academic leader in the field of digestive and liver diseases. Currently a Professor of Medicine at the University of Cantabria and Director of the Translational Research in Digestive Pathology group at IDIVAL, he has made significant contributions through over 400 original publications, more than 120 clinical trials, and leadership in numerous national and international research projects. With an H-index of 70 and over 30,000 citations, his work has had a profound global impact. He has played a pivotal role in national health strategies, including Spain’s Hepatitis C elimination plan, and served as President of major professional societies such as SEPD. A mentor to numerous doctoral and master’s students, he has also received multiple prestigious awards for his contributions to medicine and research. His leadership at Marqués de Valdecilla University Hospital earned repeated national recognition for excellence in digestive and hepatitis care.

Professional Profile 

Google Scholar
Scopus Profile
ORCID Profile 

Education

Professor Javier Crespo earned his Degree in Medicine and General Surgery from the University of Cantabria with an Outstanding qualification. He later obtained his Doctorate in Medicine in 1993, receiving the Extraordinary Doctorate Award for academic excellence. His formal education laid a strong foundation for a career marked by clinical rigor and academic depth. In addition to his medical qualifications, he has been accredited as a Professor by ANECA (the Spanish National Agency for Quality Assessment and Accreditation). His academic journey reflects not only excellence in performance but also an enduring commitment to scientific learning and advancement. His scholarly trajectory is rooted in a lifelong dedication to the field of hepatology and digestive pathology, with an early focus on merging basic medical science with clinical research. These formative years have played a crucial role in shaping his influential career in medicine, teaching, and research.

Professional Experience

Professor Crespo has held several prestigious positions throughout his career. He is a Professor of Medicine at the University of Cantabria and Director of the Translational Research in Digestive Pathology group at IDIVAL. He served as Head of the Digestive Service at Marqués de Valdecilla University Hospital from 2010 to 2024. Additionally, he has played strategic roles in healthcare governance, including being a member of Spain’s National Strategic Plan against Hepatitis C since 2015 and coordinator of the AEEH National Liver Health Plan Challenge 2032. His leadership extends to professional societies—he served as President of the Spanish Society of Digestive Pathology (SEPD), President of the National Digestive Commission, and Secretary of the Spanish Association for the Study of the Liver. His professional career reflects a unique blend of clinical excellence, policy leadership, academic mentoring, and research management, making him one of the most respected figures in his specialty.

Research Interest

Professor Crespo’s primary research interests center around digestive and liver diseases, with a particular focus on hepatitis C, liver cirrhosis, and inflammatory bowel diseases. He has led more than 120 clinical trials across Phases I–III and participated in 15 national and 8 international competitive research projects. His translational approach bridges laboratory findings with clinical application, especially in hepatology. Under his leadership, the IDIVAL research group has produced high-impact findings in digestive pathology and liver disease progression. He has authored over 400 original scientific articles, with a strong presence in high-impact journals. His work is cited more than 30,000 times, and he holds an H-index of 70, underscoring his global influence. He is also actively involved in supervising doctoral and postgraduate theses, reflecting his dedication to advancing the next generation of researchers in gastroenterology. His research has contributed significantly to public health, particularly in the management and elimination of hepatitis C.

Award and Honor

Professor Javier Crespo has received numerous national and international awards that recognize both his scientific excellence and public health impact. Among his most prestigious accolades are the Elimination Champions 2023 International Award, granted by the Coalition for Global Hepatitis Elimination, and the International Award at the VI LIFE Forum for HCV Elimination in Lima (2024). Nationally, he has been honored with the Commendation of the Civil Order of Health, the SEPD Gold Medal, and the ACAD Gold Medal. He was also named an Illustrious Torrelaveguense in 2024. Under his leadership, the Digestive Service at Marqués de Valdecilla University Hospital received the Best in Class Award for several consecutive years for excellence in digestive and hepatitis care. His honors reflect not only scientific merit but also his dedication to clinical service and public health leadership, making him one of the most decorated professionals in his field.

Conclusion

In conclusion, Professor Javier Crespo is a highly accomplished and impactful leader in the fields of gastroenterology and hepatology. His career combines outstanding academic achievement, clinical leadership, and translational research excellence. With more than 30,000 citations and an H-index of 70, his scientific contributions have shaped current practices in liver disease treatment and public health strategies. He has held top-level positions in hospitals, universities, research institutes, and national health commissions, evidencing his multifaceted influence. Through his mentorship, he has cultivated a generation of researchers and clinicians, further extending his legacy. His work has not only garnered national and international recognition through prestigious awards but has also led to meaningful improvements in patient care, especially in hepatitis C management. Professor Crespo exemplifies the qualities of a visionary researcher, a compassionate physician, and a dedicated educator—making him exceptionally worthy of recognition such as the Best Researcher Award.

Publications Top Notes

  • Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis

    • Authors: Not listed

    • Year: 2025

    • Citations: 3

  • Letter to the Editor: Optimizing MASLD treatment—A “lead-in phase” before resmetirom

    • Authors: Not listed

    • Year: Not listed

    • Citations: 1

  • Comprehensive Diagnosis of Viral Hepatitis in Spain: Bases for Implementation

    • Authors: Not listed

    • Year: 2025

  • Unraveling MASLD: The Role of Gut Microbiota, Dietary Modulation, and AI-Driven Lifestyle Interventions

    • Authors: Not listed

    • Year: Not listed

    • Citations: 1

  • A multisociety Delphi consensus statement on new fatty liver disease nomenclature

    • Authors: ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, …

    • Year: 2023

    • Citations: 4,096

  • Host recognition of bacterial muramyl dipeptide mediated through NOD2: implications for Crohn’s disease

    • Authors: N Inohara, Y Ogura, A Fontalba, O Gutierrez, F Pons, J Crespo, K Fukase, …

    • Year: 2003

    • Citations: 2,245

  • Modeling NAFLD disease burden in 8 countries (2016–2030)

    • Authors: C Estes, QM Anstee, MT Arias-Loste, H Bantel, S Bellentani, J Caballeria, …

    • Year: 2018

    • Citations: 2,027

  • A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

    • Authors: HSA Newsome, PN Buchholtz, K Cusi, M Linder, T Okanoue, V Ratziu, S Sanyal, …

    • Year: 2021

    • Citations: 1,673

  • Obeticholic acid for the treatment of NASH: Phase 3 trial analysis

    • Authors: ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, …

    • Year: 2019

    • Citations: 1,286

  • Elafibranor resolves NASH without fibrosis worsening

    • Authors: SA Ratziu, V Harrison, S Francque, P Bedossa, P Lehert, L Serfaty, …

    • Year: 2016

    • Citations: 1,217

  • Sofosbuvir and ribavirin in HCV genotypes 2 and 3

    • Authors: ER Zeuzem, S Dusheiko, GM Salupere, R Mangia, A Flisiak, RH Hyland, …

    • Year: 2014

    • Citations: 1,048

  • A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis

    • Authors: Not listed

    • Year: 2024

    • Citations: 983

  • Gene expression of TNF-α and TNF receptors in NASH patients

    • Authors: J Crespo, A Cayón, P Fernández‐Gil, M Hernández‐Guerra, M Mayorga, …

    • Year: 2001

    • Citations: 971

  • Advancing the global public health agenda for NAFLD: Consensus statement

    • Authors: JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, …

    • Year: 2022

    • Citations: 683

Jihong Hu | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Prof. Jihong Hu | Medicine and Dentistry | Best Researcher Award

Teacher at Gansu University of Chinese Medicine, China

Jihong Hu is a distinguished professor and researcher specializing in Preventive Medicine, Epidemiology, and Health Statistics. With over two decades of experience in medical research, she has contributed extensively to chronic disease prevention, traditional Chinese medicine, and public health. Her work integrates modern epidemiological methods with innovative biomedical approaches, addressing critical health challenges such as hypertension, cardiovascular diseases, and respiratory infections. She has played a key role in multiple national and provincial research projects, significantly impacting both theoretical research and practical applications in healthcare. Her commitment to advancing medical knowledge has made her a highly respected figure in the scientific community, and her contributions continue to shape the future of preventive medicine and public health.

Professional Profile

Google Scholar

Education

Jihong Hu’s academic journey began at Ningxia Medical University, where she completed both her Master’s (1995-2000) and Undergraduate degree (2000-2003) in Preventive Medicine. She then pursued a Doctorate (2004-2007) in Epidemiology and Health Statistics at the prestigious Peking Union Medical College. Her education laid a strong foundation in disease prevention, statistical health analysis, and clinical research methodologies. Through rigorous training and interdisciplinary studies, she acquired expertise in both traditional Chinese medicine and modern epidemiological practices, allowing her to bridge the gap between ancient healing techniques and contemporary medical advancements. Her academic excellence and extensive research work have positioned her as a leading scholar in the medical field.

Professional Experience

Currently serving as a Professor, Jihong Hu has held several academic and research positions, contributing to multiple high-impact projects. She has been an investigator in major studies funded by the National Natural Science Foundation of China, the Chinese Academy of Medical Sciences (CAMS) Innovative Project Engineering, and various provincial-level research initiatives. Her expertise extends to developing strategies for the prevention and management of chronic diseases, as well as evaluating the effectiveness of integrative medicine. Beyond research, she is an esteemed educator, mentoring postgraduate students and leading innovative studies in epidemiology and disease modeling. Her influence extends beyond academia, as she collaborates with public health organizations and policymakers to implement research-driven healthcare interventions.

Research Interests

Jihong Hu’s research focuses on preventive medicine, chronic disease epidemiology, and integrative traditional Chinese medicine. She has conducted groundbreaking studies on the effects of hypertension and cardiovascular diseases, examining factors such as salt sensitivity, gut microbiota, and genetic predispositions. Her work also includes epidemiological modeling of infectious diseases, exploring predictive methods for influenza, AIDS, and pediatric respiratory infections. A significant part of her research is dedicated to integrating Chinese medicine with modern healthcare, particularly in the treatment of stroke, hypertension, and myocardial infarction. Her studies have contributed to understanding the interaction between environmental and genetic factors in disease progression, offering valuable insights into early disease prevention and intervention.

Awards and Honors

Jihong Hu has received numerous awards and honors for her contributions to medical research and public health. Her work has been recognized by national and provincial scientific communities, earning her grants from esteemed institutions such as the National Natural Science Foundation of China. She has been a lead investigator in multiple high-profile projects, gaining accolades for her innovative research in chronic disease prevention. Her publications in renowned medical journals and leadership in public health initiatives have further solidified her reputation as a leading researcher. Additionally, she has been acknowledged for her mentorship and contributions to academia, shaping the next generation of medical researchers. Her achievements continue to influence the advancement of preventive medicine and integrated healthcare worldwide.

Conclusion

Jihong Hu is a highly qualified candidate for the Best Researcher Award, given her strong publication record, impactful research projects, and contributions to preventive medicine and public health. While her work is impressive, greater international collaborations and clinical research leadership could further elevate her profile. Nevertheless, she is a deserving nominee based on her extensive contributions to medical research.

Publications Top Noted

  • Effects of salt substitutes on blood pressure: a meta-analysis of randomized controlled trials

    • Author(s): YG Peng, W Li, XX Wen, Y Li, JH Hu, LC Zhao
    • Year: 2014
    • Cited by: 91

  • Effects of salt substitute on pulse wave analysis among individuals at high cardiovascular risk in rural China: a randomized controlled trial

    • Author(s): J Hu, X Jiang, N Li, X Yu, V Perkovic, B Chen, L Zhao, B Neal, Y Wu
    • Year: 2009
    • Cited by: 40

  • Clinicopathological and prognostic significance of PD-L1 expression in colorectal cancer: a meta-analysis

    • Author(s): S Wang, B Yuan, Y Wang, M Li, X Liu, J Cao, C Li, J Hu
    • Year: 2021
    • Cited by: 24

  • Effects of salt substitute on home blood pressure differs according to age and degree of blood pressure in hypertensive patients and their families

    • Author(s): J Hu, L Zhao, B Thompson, Y Zhang, Y Wu
    • Year: 2018
    • Cited by: 23

  • Effects of long-term exposure to PM2.5 and chemical constituents on blood lipids in an essential hypertensive population: a multi-city study in China

    • Author(s): R Lei, Z Wang, X Wang, H Tian, B Wang, B Xue, Y Xiao, J Hu, K Zhang, …
    • Year: 2022
    • Cited by: 11

  • Residential greenspace and blood lipids in an essential hypertension population: mediation through PM2.5 and chemical constituents

    • Author(s): R Lei, L Zhang, X Liu, C Liu, Y Xiao, B Xue, Z Wang, J Hu, Z Ren, B Luo
    • Year: 2024
    • Cited by: 6

  • Association between salt sensitivity of blood pressure and the risk of hypertension in a Chinese Tibetan population

    • Author(s): E Zhou, R Lei, X Tian, C Liu, J Guo, L Jin, H Jin, S Wang, L Cao, …
    • Year: 2023
    • Cited by: 5

  • Natural variances in blood pressure category among Chinese adults

    • Author(s): J Hu, Y Wu, L Zhao, Y Li, B Zhou
    • Year: 2008
    • Cited by: 4

  • The influence of benazepril and amlodipine on the expression of secretin and somatostatin in spontaneously hypertensive rats

    • Author(s): H Jin, ZJ Liu, CL Yan, FL Liu, L Chen, QJ Zhang, HQ Xu, JH Hu, RH Dou, …
    • Year: 2018
    • Cited by: 3

  • Unraveling the gut microbiota’s role in salt-sensitive hypertension: current evidences and future directions

    • Author(s): L Wang, J Hu
    • Year: 2024
    • Cited by: 2

  • Associations of PM2.5 composition and green space with metabolic syndrome in a Chinese essential hypertensive population

    • Author(s): Y Xiao, C Liu, R Lei, Z Wang, X Wang, H Tian, B Xue, E Zhou, K Zhang, …
    • Year: 2023
    • Cited by: 2

  • Seasonal peak and the role of local weather in schizophrenia occurrence: A global analysis of epidemiological evidence

    • Author(s): J Hu, Y Feng, H Su, Z Xu, HC Ho, H Zheng, W Zhang, J Tao, K Wu, …
    • Year: 2023
    • Cited by: 2

  • Impact of hot and cold nights on pneumonia hospitalisations in children under five years: Evidence from low-, middle-, and high-income countries

    • Author(s): Y Feng, Z Xu, MZ Hossain, J Chang, H Su, J Hu, X Wang, H Zheng, …
    • Year: 2024
    • Cited by: 1

  • Ambient temperature and the risk of childhood epilepsy hospitalizations: Potentially neglected risk of temperature extremes and modifying effects of air pollution

    • Author(s): Y Fan, J Hu, L Qiu, K Wu, Z Li, Y Feng, Q Wu, M Yang, J Tao, J Song, …
    • Year: 2024
    • Cited by: 1

  • Effects of bone marrow cells transplantation for acute myocardial infarction on cardiac function, infarct size, and clinical events: a meta-analysis

    • Author(s): S Wang, J Hu, G Dong, M Ma, X Chen, F Ding
    • Year: 2023
    • Cited by: 1

  • Rate and risk factors of metabolic components and component combinations according to hypertension status in Tibetans in a cross-sectional study

    • Author(s): J Hu, B Thompson, S Wang, M Guo, C Yan, F Ding, P Guo, L Chen, Z Cao, …
    • Year: 2022
    • Cited by: 1

  • Epidemiological survey of characteristics of metabolic syndrome in Gannan Tibetan population

    • Author(s): ZY Zhao Yi, HJH Hu JiHong, ZGS Zheng GuiSen, JLM Jin LiMei, …
    • Year: 2016
    • Cited by: 1

  • Screening and Validation of Potential Biomarkers of Immune Cells in Childhood Asthma Patients via Mendelian Randomization and Machine Learning

    • Author(s): Y Zhang, Y Hai, B Song, J Xu, L Cao, R Yasen, W Xu, J Zhang, J Hu
    • Year: 2025
    • Cited by: Not yet cited

  • Effect of compound exposure to snowstorm and cold spell on acute myocardial infarction mortality

    • Author(s): J Hu, Z Li, J Zhu, Q He, W Cheng, Q Cheng, Y Fan, H Su, H Wang, Z Bai, …
    • Year: 2025
    • Cited by: Not yet cited

  • Prevalence of lumbar disc herniation and its associated factors: A cross-sectional study in Gansu

    • Author(s): Z Chen, J Zhao, L Wang, H Shao, L Cao, X He, Z Yang, J Ma, Q Chen, …
    • Year: 2024
    • Cited by: 0

 

Pedro Abreu Sánchez | Dentistry | Best Researcher Award

Published on by World Top Scientists

Dr. Pedro Abreu Sánchez | Dentistry | Best Researcher Award

Facultativo Especialista en Medicina Nuclear, Servicio de Medicina Nuclear Hospital Universitario Dr. Peset (Valencia), Spain

Pedro Abreu Sánchez is a distinguished specialist in Nuclear Medicine, renowned for his extensive experience in public and private healthcare settings. With over 20 years in the field and a notable academic career, he is recognized for his expertise in radioguided surgery and diagnostic imaging. Dr. Abreu’s commitment to education and research, combined with his roles in various professional committees, highlights his significant contributions to the advancement of nuclear medicine.

Profile

Scopus

Research for Best Researcher Award Evaluation: Pedro Abreu Sánchez

Strengths for the Award

  1. Extensive Experience in Medicine and Nuclear Medicine:
    • Pedro Abreu Sánchez has over 20 years of experience in public healthcare and 9 years in private healthcare, showcasing a strong professional background in nuclear medicine.
  2. Academic Achievements:
    • He holds a Doctor “Cum Laude” in Medicine and Surgery from the Universitat de València, indicating high academic excellence.
    • He also possesses a Diploma de Estudios Avanzados, further solidifying his academic credentials.
  3. Teaching and Mentorship:
    • Pedro is actively involved in teaching as a professor and tutor, contributing to the education of future medical professionals. This role highlights his dedication to knowledge dissemination and mentorship.
  4. Research Involvement:
    • He has served as the principal investigator and adjunct investigator in significant research projects such as Polisabio “IEPET-er” and “Calysap Fénix”.
    • Pedro has contributed to over 80 scientific publications and more than 50 conference communications, demonstrating prolific research output and active engagement in scientific discourse.
  5. Professional Memberships and Roles:
    • His membership in various professional committees and groups, such as SEMNIM and the Fundación FISABIO, indicates his active participation and leadership in the medical and scientific communities.
    • His role in the Comisión Nacional de la especialidad de medicina nuclear of the Ministry of Health, Equality and Social Affairs of Spain underscores his influence and recognition in the field.

Areas for Improvement

  1. Broader International Collaboration:
    • While Pedro has a strong national presence, increased collaboration with international researchers and participation in global projects could enhance his research impact and visibility.
  2. Interdisciplinary Research:
    • Expanding his research to include more interdisciplinary projects could further enrich his work and open new avenues for innovation and application of nuclear medicine.
  3. Grant Acquisition:
    • Proactively seeking and securing more research grants could bolster his research capabilities and allow for larger, more ambitious projects.
  4. Publication in High-Impact Journals:
    • While he has a substantial number of publications, focusing on publishing in higher-impact journals could increase the visibility and influence of his research findings.

Education 🎓

  • Doctorate in Medicine and Surgery (2023)
    • Institution: Universitat de València
    • Thesis Title: “Eficacia y eficiencia de la Cirugía radioguiada en el hiperparatiroidismo primario: revisión de las diferentes técnicas disponibles”
  • Diploma of Advanced Studies (DEA) (2017)
    • Institution: Universitat de València
  • Licentiate in Medicine and Surgery (1997)
    • Institution: Universitat de València

Experience 💼

  • Professor Assistencial Docente (2018-Present)
    • Institution: Universitat de València, Departament de Medicina, Facultat de Medicina y Cirugia
    • Responsibilities: Responsible for and teaching hospital practices in the Clinical Radiology course for 4th-year medical students
  • Facultativo Especialista (2002-Present)
    • Institution: Hospital Universitario Dr. Peset
    • Responsibilities: Diagnosis, treatment, and research using radiopharmaceuticals
  • Facultativo Especialista en Medicina Nuclear (2002-2011)
    • Institution: VIAMEDIC
  • Médico Interno Residente (1998-2002)
    • Institution: Hospital Universitario Doctor Peset

Research Interests 🔬

Dr. Abreu’s research focuses on the efficacy and efficiency of radioguided surgery, particularly in primary hyperparathyroidism, and the application of diagnostic imaging techniques. He is deeply involved in advancing methodologies for radioguided surgeries and exploring the clinical relevance of imaging in various medical conditions.

Awards 🏆

Pedro Abreu Sánchez has been recognized for his contributions to nuclear medicine and radioguided surgery. His accolades include various awards and grants supporting his research and clinical practice, affirming his standing as a leading expert in his field.

Publications Top Notes 📚

  1. Goñi-Gironés, E., Fuertes-Cabero, S., Blanco-Sáiz, I., Díaz-Expósito, R., Vidal-Sicart, S., Abreu Sánchez, P. (2021). Eficacia y eficiencia de la Cirugía radioguiada en el hiperparatiroidismo primario: revisión de las diferentes técnicas disponibles. Revista Española de Medicina Nuclear e Imagen Molecular, 40(1), pp. 57–66. Link
    • Cited by: Salvador García, J., Abreu Sánchez, P., Delgado Cordón, F., Cueto Cañadas, B., Latorre Agraz, I. (2018). Utility of diagnostic imaging in the diagnosis of extra adrenal myelolipoma. Revista Española de Medicina Nuclear e Imagen Molecular, 37(6), pp. 395–396.
  2. Salvador García, J., Abreu Sánchez, P., Delgado Cordón, F., Cueto Cañadas, B., Latorre Agraz, I. (2018). Utility of diagnostic imaging in the diagnosis of extra adrenal myelolipoma. Revista Española de Medicina Nuclear e Imagen Molecular, 37(6), pp. 395–396. Link
    • Cited by: Frontado-Morales, L., Martinez-Sanchis, B., Sanchez-Vaño, R., Abreu Sánchez, P., Reyes-Ojeda, M.D. (2012). Radioguided cervical lymphadenectomy in one case of recurrence of differentiated thyroid microcarcinoma. Revista Española de Medicina Nuclear e Imagen Molecular, 31(2), pp. 106–107.
  3. Frontado-Morales, L., Martinez-Sanchis, B., Sanchez-Vaño, R., Abreu Sánchez, P., Reyes-Ojeda, M.D. (2012). Radioguided cervical lymphadenectomy in one case of recurrence of differentiated thyroid microcarcinoma. Revista Española de Medicina Nuclear e Imagen Molecular, 31(2), pp. 106–107. Link
    • Cited by: Plancha-Mansanet, M.C., Félix-Fontestad, J., Caballero-Calabuig, E., Sopena-Novales, P., Martínez-Sanchís, B. (2010). Effect of transport temperature on the scantibodies total intact parathyroid hormone immunoradiometric assay using the RIAMAT-280. Annals of Clinical Biochemistry, 47(2), pp. 174–176.
  4. Plancha-Mansanet, M.C., Félix-Fontestad, J., Caballero-Calabuig, E., Sopena-Novales, P., Martínez-Sanchís, B. (2010). Effect of transport temperature on the scantibodies total intact parathyroid hormone immunoradiometric assay using the RIAMAT-280. Annals of Clinical Biochemistry, 47(2), pp. 174–176. Link

Conclusion

Pedro Abreu Sánchez is a highly qualified candidate for the Best Researcher Award, given his extensive experience, academic achievements, significant research contributions, and active engagement in teaching and professional communities. His dedication to nuclear medicine, demonstrated through both his clinical work and research, makes him a strong contender for the award. By expanding his international collaborations, engaging in more interdisciplinary research, securing additional grants, and targeting high-impact journals for publication, he can further enhance his impressive profile and research impact.